Does adding online hypnotherapy to usual care improve blood pressure control in adults with hypertension?
| ISRCTN | ISRCTN16573611 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN16573611 |
| Sponsor | Misrata Heart & Cardiovascular Center |
| Funder | Investigator initiated and funded |
- Submission date
- 03/10/2026
- Registration date
- 08/10/2026
- Last edited
- 08/10/2026
- Recruitment status
- Not yet recruiting
- Overall study status
- Ongoing
- Condition category
- Circulatory System
Plain English summary of protocol
Background and study aims
This study will examine whether online hypnotherapy added to usual medical care helps adults with high blood pressure (hypertension) improve their blood pressure control.
Who can participate?
Adults aged 18–50 years with grade I–II essential hypertension
What does the study involve?
Participants recruited through the researcher's website will continue their usual treatment plus at least eight weekly, 60-minute online hypnotherapy sessions. Participants recruited at Misrata Heart & Cardiovascular Center (MHCC) will receive optimal medical treatment alone. Assignment depends on where participants are recruited; it is not random. Each participant will be followed for 24 weeks. Blood pressure will be measured with a 24-hour monitor at the start, at 12 weeks and at 24 weeks. Participants will also keep a home blood pressure diary and complete questionnaires about stress and well-being.
What are the possible benefits and risks of participating?
Improvement cannot be guaranteed. Online sessions may be emotionally uncomfortable for some participants. Usual prescribed treatment continues. There is no direct harm risk.
Where is the study run from?
Misrata Heart & Cardiovascular Center (MHCC) (Libya)
When is the study starting and how long is it expected to run for?
December 2026 to December 2030
Who is funding the study?
Investigator initiated and funded
Who is the main contact?
Dr Vladislav Tettegah, director@drvladt.com
Contact information
Public, Scientific, Principal investigator
El Ghiran, Nusur El Jew village, MHCC building
Misrata
N/A
Libya
| Phone | +375 (0)259414873 |
|---|---|
| director@drvladt.com |
Study information
| Primary study design | Interventional |
|---|---|
| Allocation | Non-randomized controlled trial |
| Masking | Open (masking not used) |
| Control | Active |
| Assignment | Parallel |
| Purpose | Health services research, Prevention, Supportive care, Treatment |
| Scientific title | Adjunctive online Ericksonian non-directive hypnotherapy compared with standard antihypertensive care alone for 24-hour systolic blood pressure in adults aged 18–50 years with grade I–II essential hypertension: a prospective, open-label, non-randomised controlled study |
| Study objectives | To assess whether adding structured online Ericksonian non-directive hypnotherapy to standard antihypertensive care improves mean 24-hour systolic blood pressure over 24 weeks compared with standard antihypertensive care alone in adults with grade I–II essential hypertension. |
| Ethics approval(s) |
Submitted 26/09/2026, Misrata Heart & Cardiovascular Center Ethics Committee (El Ghiran, Nusur El Jew village, MHCC building, Misrata, N/A, Libya; +974 (0)77447492; v.delgado@apexhealth-libq.com), ref: MHCC/RES/2026/002 |
| Health condition(s) or problem(s) studied | Grade I–II essential arterial hypertension with suboptimal blood pressure control |
| Intervention | This is a prospective, open-label, non-randomised, parallel-group study lasting 24 weeks per participant. Recruitment is planned in Romania and Libya. Eligible participants recruited through the researcher's website enter the online hypnotherapy group; eligible participants recruited at MHCC enter the usual-care comparison group. The intervention group, including participants in Romania, will be recruited through the investigator's website (https://www.drvladt.com/) and will receive standard, clinician-directed antihypertensive care plus a structured online programme of Ericksonian non-directive hypnotherapy incorporating regression techniques. Each intervention participant is planned to receive at least eight online sessions during the 24-week follow-up. The comparison group will be recruited at Misrata Heart & Cardiovascular Center (MHCC), Libya, and will receive standard, clinician-directed antihypertensive care without the additional study hypnotherapy. Antihypertensive treatment may be adjusted as clinically indicated in either group. Both groups are planned to have 24-hour ambulatory blood pressure monitoring at baseline, week 12 and week 24; psychological questionnaires at baseline and week 24; and a home blood pressure diary. Session frequency and duration, the exact non-randomised assignment procedure, the Romanian participating centre, and arrangements for clinical monitoring in each participating country remain to be finalised in the protocol. |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
|
| Key secondary outcome measure(s) |
|
| Completion date | 31/12/2030 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 50 Years |
| Sex | All |
| Target sample size at registration | 200 |
| Key inclusion criteria | 1. Adults aged 18–50 years 2. Grade I–II essential hypertension confirmed by office blood pressure measurement and/or 24-hour ambulatory blood pressure monitoring (ABPM) 3. Suboptimal blood pressure control at screening, based on office measurement, a home blood pressure diary and/or ABPM 4. Standard antihypertensive therapy for at least 4 weeks before enrolment, or no previously prescribed regular treatment with the possibility of initiating it after enrolment 5. Access to a smartphone or computer and the internet, and ability to attend online sessions and complete questionnaires 6. Willingness to undergo baseline, interim and final assessments, including ABPM and psychometric questionnaires 7. Written informed consent 8. For the intervention group: motivation to address psychosocial factors and willingness to participate in hypnotherapy sessions |
| Key exclusion criteria | 1. Acute cardiovascular event within the preceding 6 months (myocardial infarction, unstable angina, stroke, transient ischaemic attack or coronary intervention) 2. New York Heart Association (NYHA) class II–IV heart failure; clinically significant arrhythmia that interferes with ABPM or heart rate variability assessment; severe valvular disease or pulmonary hypertension 3. Suspected or confirmed secondary hypertension; severe or decompensated thyroid disease; estimated glomerular filtration rate below 60 ml/min/1.73 m²; severe liver disease 4. Pregnancy or breastfeeding 5. Active cancer or inflammatory disease requiring ongoing treatment 6. Shift or night work, or marked sleep–wake disruption likely to affect the daily blood pressure profile 7. Psychotic disorder, manic episode or marked cognitive impairment 8. Current psychotherapy or regular psychotropic medication likely to materially affect psychological outcomes 9. Inability to participate regularly in online sessions, complete questionnaires or maintain a home blood pressure diary |
| Date of first enrolment | 31/12/2026 |
| Date of final enrolment | 30/06/2030 |
Locations
Countries of recruitment
- Libya
- Romania
Study participating centre
Misrata
-
Libya
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan | De-identified IPD underlying published results will be available from the PI on reasonable request (director@drvladt.com), subject to consent, ethics and sponsor approval, and a data-use agreement. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol file | 07/10/2026 | No | No |
Additional files
- 50402_PROTOCOL.pdf
- Protocol file
Editorial Notes
05/10/2026: Study's existence confirmed by the Misrata Heart & Cardiovascular Center.